Unknown

Dataset Information

0

Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support


ABSTRACT:

Background:

Though controversial, the short-duration in-patient use of inotropes in cardiogenic shock (CS) remain an ACC/AHA Class IIa indication, and are frequently used in the initial treatment of CS. We evaluated in-patient mortality and effect on mortality risk of commonly used vasoactive inotropic medications for the medical management of SCAI stage B and C cardiogenic shock patients in a tertiary care cardiac care unit: dobutamine, dopamine, milrinone, and norepinephrine.

Methods:

We retrospectively evaluated 342 patients who received dobutamine, milrinone, dopamine, norepinephrine or a combination of these medications for SCAI stage B and C cardiogenic shock. Cox proportional hazards were used to form longitudinal mortality predictions.

Results:

Overall in-patient mortality was 18%. Each 1 µg/kg/minute increase in dobutamine independently corresponded to a 15% increase in risk of mortality. High dose dobutamine >3 µg/kg/minute is associated with 3-fold increased risk compared to ⩽3 µg/kg/minute (P < .001). Use of milrinone, norepinephrine, and dopamine were not independently associated with mortality.

Conclusion:

We demonstrate that the overall in-hospital mortality of SCAI stage B and C cardiogenic shock patients medically managed on inotropes was not in excess of prior studies. Dobutamine was independently associated with mortality, while other vasoactive inotropic medications were not. Inotropes remain a feasible method of managing SCAI stage B and C cardiogenic shock.

SUBMITTER: Nandkeolyar S 

PROVIDER: S-EPMC8554565 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8842943 | biostudies-literature
| S-EPMC8293961 | biostudies-literature
| S-EPMC10118996 | biostudies-literature
| S-EPMC8049792 | biostudies-literature
| S-EPMC6435836 | biostudies-literature
| S-EPMC8649539 | biostudies-literature
| S-EPMC8413249 | biostudies-literature
| S-EPMC4191250 | biostudies-literature
| S-EPMC7439249 | biostudies-literature
| S-EPMC11010074 | biostudies-literature